ArchPoint Investors - VBI VACCINES INC ownership

VBI VACCINES INC's ticker is VBIV and the CUSIP is 91822J103. A total of 124 filers reported holding VBI VACCINES INC in Q4 2020. The put-call ratio across all filers is 2.75 and the average weighting 0.0%.

Quarter-by-quarter ownership
ArchPoint Investors ownership history of VBI VACCINES INC
ValueSharesWeighting
Q3 2022$46,000
-13.2%
65,0000.0%0.02%
-9.5%
Q2 2022$53,000
-50.9%
65,0000.0%0.02%
-43.2%
Q1 2022$108,000
-28.9%
65,0000.0%0.04%
-17.8%
Q4 2021$152,000
-24.8%
65,0000.0%0.04%
-26.2%
Q3 2021$202,000
-7.3%
65,0000.0%0.06%
-17.6%
Q2 2021$218,000
-12.4%
65,000
-18.8%
0.07%
+4.2%
Q1 2021$249,000
+13.2%
80,0000.0%0.07%
+16.4%
Q4 2020$220,000
+18.3%
80,000
+23.1%
0.06%
+3.4%
Q3 2020$186,00065,0000.06%
Other shareholders
VBI VACCINES INC shareholders Q4 2020
NameSharesValueWeighting ↓
Perceptive Advisors 55,042,465$171,182,0002.49%
GENERAL AMERICAN INVESTORS CO INC 1,877,497$5,839,0000.50%
HighVista Strategies LLC 41,271$129,0000.08%
ArchPoint Investors 65,000$202,0000.06%
FIRST MIDWEST BANK TRUST DIVISION 136,714$425,0000.06%
FNY Investment Advisers, LLC 24,683$76,0000.04%
GRIMES & COMPANY, INC. 257,960$802,0000.04%
Cambridge Investment Research Advisors, Inc. 2,065,953$6,425,0000.03%
Ergoteles LLC 171,127$532,0000.02%
J.W. COLE ADVISORS, INC. 71,100$221,0000.02%
View complete list of VBI VACCINES INC shareholders